Skip to Main Content
1
Yale Neurology
Yale Physicians Building
800 Howard Avenue
New Haven, CT 06519
1 of 2

Hardik P Amin, MD

Stroke
Telehealth is available
Learn more about telehealth
Patient type treated
Adult
Accepting new patients
Yes
Referral required
From physicians only

Biography

Hardik P. Amin, MD, is a stroke specialist who helps patients and families determine treatment plans for stroke and cerebrovascular disease. “Stroke incorporates both acute treatment in the emergency room and long-term care in the outpatient clinic,” Dr. Amin says. “I follow my patients over the course of their recovery and guide them in the prevention of future strokes.”

Treatment for stroke, including tissue plasminogen activator (tPA) and novel anticoagulants for secondary stroke prevention, continue to evolve, Dr. Amin says. “There are still many avenues that need further research, but our ability to diagnose and treat stroke is becoming more and more sophisticated. He works closely with neurosurgical and cardiology colleagues to ensure patients have seamless transitions among different subspecialties.

An assistant professor of neurology at Yale School of Medicine, Dr. Amin also researches carotid artery disease and its implications for future stroke. “We offer a variety of clinical trials that are not available at other institutions,” he says.

Titles

  • Associate Professor Term
  • Medical Stroke Director, Yale New Haven Hospital, St. Raphael Campus, Neurology

Education & Training

  • Fellowship
    Yale University School of Medicine (2014)
  • Residency
    Yale-New Haven Hospital (2013)
  • MD
    Drexel University College of Medicine (2009)
  • BS
    University of New Hampshire, Molecular Biology (2004)

Languages Spoken

  • English
  • ગુજરાતી (Gujarati)

Additional Information

Locations
1
Yale Neurology
Yale Physicians Building
800 Howard Avenue
New Haven, CT 06519
1 of 2

Biography

Hardik P. Amin, MD, is a stroke specialist who helps patients and families determine treatment plans for stroke and cerebrovascular disease. “Stroke incorporates both acute treatment in the emergency room and long-term care in the outpatient clinic,” Dr. Amin says. “I follow my patients over the course of their recovery and guide them in the prevention of future strokes.”

Treatment for stroke, including tissue plasminogen activator (tPA) and novel anticoagulants for secondary stroke prevention, continue to evolve, Dr. Amin says. “There are still many avenues that need further research, but our ability to diagnose and treat stroke is becoming more and more sophisticated. He works closely with neurosurgical and cardiology colleagues to ensure patients have seamless transitions among different subspecialties.

An assistant professor of neurology at Yale School of Medicine, Dr. Amin also researches carotid artery disease and its implications for future stroke. “We offer a variety of clinical trials that are not available at other institutions,” he says.

Titles

  • Associate Professor Term
  • Medical Stroke Director, Yale New Haven Hospital, St. Raphael Campus, Neurology

Education & Training

  • Fellowship
    Yale University School of Medicine (2014)
  • Residency
    Yale-New Haven Hospital (2013)
  • MD
    Drexel University College of Medicine (2009)
  • BS
    University of New Hampshire, Molecular Biology (2004)

Languages Spoken

  • English
  • ગુજરાતી (Gujarati)

Additional Information

Locations
1
Yale Neurology
Yale Physicians Building
800 Howard Avenue
New Haven, CT 06519
1 of 2
1
Yale Neurology
Yale Physicians Building
800 Howard Avenue
New Haven, CT 06519
1 of 2